Results 141 to 150 of about 13,660 (185)

Real-World Multicenter Cohort Study of Inebilizumab vs Low-Dose Rituximab in Neuromyelitis Optica Spectrum Disorders. [PDF]

open access: yesNeurol Neuroimmunol Neuroinflamm
Xu Q   +21 more
europepmc   +1 more source

AQP4-IgG and mood disorders: Case series of neuromyelitis optica spectrum disorder. [PDF]

open access: yesBrain Behav Immun Health
Xu Q   +6 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Neuromyelitis optica

Current Treatment Options in Neurology, 2005
Neuromyelitis optica (Devic's syndrome) is an uncommon, idiopathic, demyelinating syndrome of the central nervous system that preferentially affects the optic nerves and spinal cord. It frequently is misdiagnosed as severe multiple sclerosis, but usually is readily distinguished from multiple sclerosis in fully developed cases because of its severity ...
Dean M, Wingerchuk, Brian G, Weinshenker
  +9 more sources

Neuromyelitis optica

Nature Reviews Disease Primers, 2020
Neuromyelitis optica (NMO; also known as Devic syndrome) is a clinical syndrome characterized by attacks of acute optic neuritis and transverse myelitis. In most patients, NMO is caused by pathogenetic serum IgG autoantibodies to aquaporin 4 (AQP4), the most abundant water-channel protein in the central nervous system.
Sven, Jarius   +5 more
openaire   +4 more sources

Neuromyelitis Optica

Current Treatment Options in Neurology, 2010
Neuromyelitis optica (NMO) or Devic's disease typically involves the optic nerves and the spinal cord and is most often relapsing. The pathogenesis is one of an acute inflammatory process targeting astrocytes and resulting in demyelination, as well as axonal injury.
William M, Carroll, Kazuo, Fujihara
openaire   +4 more sources

Neuromyelitis optica and neuromyelitis optica spectrum disorders

Current Opinion in Neurology, 2017
Purpose of review The discovery of highly specific auto-antibodies directed against the water channel aquaporin 4 was a quantum leap in the definition, classification and management of neuromyelitis optica (NMO). Herein, we propose an update on epidemiological, clinical and therapeutic advances in the field, underlining unmet ...
Romain, Marignier   +2 more
openaire   +4 more sources

Neuromyelitis optica and neuromyelitis optica spectrum disorders

Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2019
The review is devoted to up-to-date data on epidemiology, aspects of the pathogenesis of neuromyelitis optica (NMO) and neuromyelitis optica spectrum disorders (NMOSD). The authors consider a role of myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG) in the syndromes phenotypically similar to NMO and NMOSD. Special attention is drawn to the
T.O. Simaniv   +3 more
openaire   +2 more sources

Headache in Neuromyelitis Optica

Current Pain and Headache Reports, 2017
Neuromyelitis optica (NMO) classically features a clinical presentation that includes longitudinally extensive transverse myelitis and optic neuritis. However, many other pathognomonic phenomena have more recently been described in patients diagnosed with NMO, including intractable hiccups, vomiting, and painful tonic spasms, but less has been reported
Alina, Masters-Israilov   +1 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy